Human iPSC-Derived Sensory Neurons for Functional Sensory Biology and Pharmacology Research
Get an exclusive first look at BrainXell’s newly launched human iPSC-derived sensory neurons and learn how they enable reproducible, human-relevant models for sensory transduction, pharmacology, and ion channel research.
Photoreceptor Cell Therapy to Treat Advanced Retinal Degeneration
Dr. Rachael Pearson explores how transplanting human stem cell-derived cone photoreceptors can functionally restore vision and light-evoked behavior in cases of advanced retinal degeneration.
Exploring the iPSC-Derived Neuronal-Glia Co-culture System: A Powerful Drug Discovery Platform for Studying Neurodegenerative Diseases
Learn how FUJIFILM’s iPSC-derived neuron-glia co-culture system supports drug discovery and disease modeling for neurodegenerative disorders.
#ExpertAnswers: Andrew Gaffney and Erin Knock on Neural Progenitor Cell Differentiation
Experts from STEMCELL Technologies answer questions from a webinar presenting an iPSC line and its differentiation into neural cells.
Advancing Disease Modeling for Drug Discovery by Modulating iPSCs with CRISPR and Neuronal Differentiation
Explore applications of CRISPR and iPSCs in disease modeling and drug discovery in our upcoming webinar with Synthego and BrainXell.
Fully Characterized, Standardized Human Induced Pluripotent Stem Cell Line and Ready-to-Use, High-Quality Neural Progenitor Cells for Downstream Differentiation Applications
On June 29, 2023, STEMCELL Technologies' Dr. Andrew Gaffney and Dr. Erin Knock presented on how to streamline PSC-related workflows using highly characterized induced pluripotent stem cells (iPSCs) and neural progenitor cells (NPCs), and how to differentiate these cells into a variety of cell types downstream. In this Q&A report, you can read their answers to questions asked by the audience. Answers have been edited for length and/or clarity.
Cellular Brain Repair for Parkinson’s Disease: Is the Answer in the (Biomaterial) Matrix?
Hear Eilís Dowd, PhD highlight her lab's recent data demonstrating that dopaminergic cell replacement in the Parkinsonian rodent brain, using both fetal and induced stem cell-derived cells, is enhanced when the cells are transplanted in a neurotrophin-enriched collagen hydrogel.
Fully Characterized, Standardized Human Induced Pluripotent Stem Cell Line and Ready-to-Use, High-Quality Neural Progenitor Cells for Downstream Differentiation Applications
In this webinar, experts present a standardized human induced pluripotent stem cell line and its differentiation into neural cells for disease modeling and assay development.
